BOX (NYSE:BOX – Free Report) had its target price lowered by Morgan Stanley from $32.00 to $30.00 in a report issued on Wednesday, Benzinga reports. The brokerage currently has an equal weight rating on the software maker’s stock. Other analysts also recently issued reports about the stock. Citigroup increased their price target on shares of […]
StockNews.com upgraded shares of GMS (NYSE:GMS – Free Report) from a buy rating to a strong-buy rating in a research note published on Wednesday morning. A number of other equities research analysts have also recently weighed in on GMS. Barclays boosted their price target on shares of GMS from $75.00 to $93.00 and gave the […]
Equities research analysts at Robert W. Baird began coverage on shares of Elevance Health (NYSE:ELV – Get Free Report) in a note issued to investors on Thursday, MarketBeat reports. The brokerage set an “outperform” rating and a $649.00 price target on the stock. Robert W. Baird’s target price suggests a potential upside of 20.53% from […]
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) has been given an average recommendation of “Moderate Buy” by the seventeen research firms that are presently covering the stock, MarketBeat reports. Seven equities research analysts have rated the stock with a hold recommendation and ten have given a buy recommendation to the company. The average 1 […]
StockNews.com cut shares of CVR Energy (NYSE:CVI – Free Report) from a buy rating to a hold rating in a research report report published on Friday. Several other research firms have also weighed in on CVI. UBS Group cut their target price on shares of CVR Energy from $37.00 to $33.75 and set a neutral […]